Kalemkerian GP - Search Results

1

Zohrabyan D, Karapetyan N, Danielyan S, Saghatelyan T, Safaryan L, Bardakhchyan S, Tamamyan G, Harutyunyan M, Rushanyan M, Mkrtchyan G, Badalyan S, Avagyan A, Harutyunyan L, Lazaryan A, Mkhitaryan S, Khanoyan A, Sargsyan A, Mailyan M, Mamunts D, Asadyan A, Khachatryan P, Mkhitaryan A, Kalemkerian GP. Zohrabyan D, et al. Among authors: kalemkerian gp. J Thorac Oncol. 2023 Apr;18(4):402-409. doi: 10.1016/j.jtho.2022.12.015. J Thorac Oncol. 2023. PMID: 36990573 Free article. No abstract available.

2

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.

Krug LM, Miller VA, Kalemkerian GP, Kraut MJ, Ng KK, Heelan RT, Pizzo BA, Perez W, McClean N, Kris MG. Krug LM, et al. Among authors: kalemkerian gp. Ann Oncol. 2000 Feb;11(2):227-8. doi: 10.1023/a:1008349209956. Ann Oncol. 2000. PMID: 10761761 Free article. Clinical Trial. No abstract available.

3

Running in Place: The 20th Anniversary of the NCCN Small Cell Lung Cancer Guidelines Panel.

Kalemkerian GP. Kalemkerian GP. J Natl Compr Canc Netw. 2015 Jun;13(6):704-6. doi: 10.6004/jnccn.2015.0084. J Natl Compr Canc Netw. 2015. PMID: 26085385 No abstract available.

4

Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.

Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL. Simon GR, et al. Among authors: kalemkerian gp. J Clin Oncol. 2008 Jul 20;26(21):3567-72. doi: 10.1200/JCO.2007.15.2868. J Clin Oncol. 2008. PMID: 18640937 Clinical Trial.

5

Small cell lung cancer.

Kalemkerian GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M, Langer CJ, Martins R, Niell HB, Pan CC, Ramnath N, Ready N, Robert F, Williams CC Jr. Kalemkerian GP, et al. J Natl Compr Canc Netw. 2008 Mar;6(3):294-314. J Natl Compr Canc Netw. 2008. PMID: 18377848 No abstract available.

6

Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.

Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI. Shridhar V, et al. Among authors: kalemkerian gp. Oncogene. 1997 Nov 27;15(22):2727-33. doi: 10.1038/sj.onc.1201448. Oncogene. 1997. PMID: 9400999

7

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. Kalemkerian GP, et al. J Natl Cancer Inst. 1995 Nov 15;87(22):1674-80. doi: 10.1093/jnci/87.22.1674. J Natl Cancer Inst. 1995. PMID: 7473815

8

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial.

Subbiah V, Cassier PA, Siena S, Garralda E, Paz-Ares L, Garrido P, Nadal E, Vuky J, Lopes G, Kalemkerian GP, Bowles DW, Seetharam M, Chang J, Zhang H, Green J, Zalutskaya A, Schuler M, Fan Y, Curigliano G. Subbiah V, et al. Among authors: kalemkerian gp. Nat Med. 2022 Aug;28(8):1640-1645. doi: 10.1038/s41591-022-01931-y. Epub 2022 Aug 12. Nat Med. 2022. PMID: 35962206 Free PMC article. Clinical Trial.

9

Tumor lysis syndrome in small cell carcinoma and other solid tumors.

Kalemkerian GP, Darwish B, Varterasian ML. Kalemkerian GP, et al. Am J Med. 1997 Nov;103(5):363-7. doi: 10.1016/s0002-9343(97)00153-8. Am J Med. 1997. PMID: 9375703 Review.

10

Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.

Ali MA, Rosati R, Pettit GR, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Anticancer Res. 1998 Mar-Apr;18(2A):1021-6. Anticancer Res. 1998. PMID: 9615758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters